72
Views
30
CrossRef citations to date
0
Altmetric
Drug Evaluation

Pharmacology and clinical experience with fedotozine

Pages 97-110 | Published online: 24 Feb 2005

Bibliography

  • DROSSMAN DA: The functional gastrointestinaldisorders and the Rome IIprocess. Gut (1999) 45:111–115.
  • WOOD JD, ALPERS DH, ANDREWS PLR: Fundamentals ofneurogastroenterology. Gut (1999) 45:116–1116.
  • KELLOW JE, DELVAUX M, AZPIROZ F, CAMILLERI M,QUIGLEY EMM, THOMPSON DG: Principles of applied neurogastroenterology: physiology/motility-sensation. Gut (1999) 45:17–24.
  • BUENO L, FIORAMONTI J, DELVAUX M, FREXINOS J:Mediators and pharmacology of visceral sensitivity: From basic to clinical investigations. Gastroenterology (1997) 112:1714–1743.
  • DHAWAN BN, CESSELIN F, RAGHUBIR R et al.: Interna-tional Union of Pharmacology. XII. Classification of opioid receptors. Pharmacol Rev. (1996) 48:567–592.
  • ALLESCHER HD, AHMAD S, CLASSEN M, DANIEL EE: Interaction of trimebutine and JO-1196 (fedotozine) with opioid receptors in the canine ileum. J. Pharmacol. Exp. Ther. (1991) 257:836–842.
  • GUE M, FIORAMONTI J, HONDE C, PASCAUD X, JUNIEN JL, BUENO L: Opposite effects of K-opioid agonists on gastric emptying of liquids and solids in dogs. Gastro-enterology (1988) 95:927–931.
  • BUENO L, FIORAMONTI J: Action of opiates on gastroin-testinal function. Baillères's Clin. Gastroenterol. (1988) 2:123–139.
  • PASCAUD X, HONDE C, LE GALLOU B et al.: Effects offedotozine on gastrointestinal motility in dogs: mechanism of action and related pharmacokinetics. Pharm. Pharmacol. (1990) 42:546–552.
  • CORUZZI G, MORINI G, COPPELLI G, BERTACCINI G: Thecontractile effect of fedotozine on guinea-pig isolated intestinal cells is not mediated by K-opioid receptors. Pharmacology (1998) 56:281–284.
  • KREVSKY B, COWAN A, MAURER AH, BUTT W, FISHER RS:Effects of selective opioid agonists on feline colonic transit. Life Sci. (1991) 48:1597–1602.
  • KREISS C, FRASER R, BOROVICKA J et al.: Intestinal sensitivity in healthy volunteers: A pilot study of the action of fedo to zin e. In: Sensitive Gastrointestinal Disorders. Galmiche JP, Fraitag B (Eds.), John Libbey Eurotext, France (1995):77–79.
  • KARAUS M: Double-blind controlled study of the activity of fedotozine administered by the iv. and intragastric routes, on intestinal motility and transit time in the healthy subject. Fedotozine Investigator Brochure. Jouveinal, Paris, France (1993):138–143.
  • DELVAUX M, LOUVEL D, LAGIER E, SCHERRER B, ABITBOL JL, FREXINOS J: The K-agonist fedotozine relieves hypersensitivity to colonic distension in patients with irritable bowel syndrome (IBS). Gastro-enterology (1999) 116:38–45.
  • GUE M, JUNIEN JL, PASCAUD X, BUENO L: Antagonism ofstress-induced gastric motor alteration and plasma cortisol by fedotozine (JO-1196) in dogs. j Gastrointest. Mot. (1990) 2:258–254.
  • RIVIERE PJ, PASCAUD X, CHEVALIER E, LE GALLOU B,JUNIEN JL: Fedotozine reverses ileus induced by surgery or peritonitis: action at peripheral K-opioid receptors. Gastroenterology (1993) 104:724–731.
  • DE WINTER BY, BOECKXSTAENS GE, DE MAN JG, MOREELS TG, HERMAN AG, PELCKMANS PA: Effects of mu and K-opioid receptors on post-operative ileus in rats. Eur. j Pharmacol. (1997) 339:63–67.
  • JONES KL, WISHART JM, BERRY MK, ABITBOL JL, HOROWITZ M: Effects of fedotozine on gastric emptying and upper gastrointestinal symptoms in diabetic gastroparesis. Aliment Pharmacol. Ther. (2000) 14:937–943.
  • PALLOTTA N, JACQUOT F, DE MEYNARD C, ABITBOL JL, CORAZZIARI E: Effect of fedotozine on symptoms and delayed gastric emptying in functional dyspeptic patients. Gastroenterology (1999) 116:A156. Abstract.
  • FERREIRA SH, NAKAMURA M: Prostaglandin hyperal-gesia. II: The peripheral analgesic activity of morphine, enkephalins and opioid antagonists. Prostaglandins (1979) 18:191–200.
  • JORIS JL, DUBNER R, HARGREAVES KM: Opioid analgesiaat peripheral sites: a target for opioids released during stress and inflammation. Anaesth. Analg. (1987) 66:1277–1281.
  • STEIN C, GRAMSCH C, HERZ A: Intrinsic mechanisms ofantinociception in inflammation: local opioid receptors and 13-endorphin. J. Neurosci. (1990) 10:1292–1298.
  • STEIN C, MILLAN MJ, SHIPPENBERG TS, PETER K, HERZ A:Peripheral opioid receptors mediating antinociciep-tion in inflammation. Evidence for involvement of µ-, 8- and K-receptors. J. Pharmacol. Exp. Ther. (1989) 248:1269–1275.
  • HASSAN AHF, ABLETINER A, TEIN C, HERZ A: Inflamma-tion of the paw enhances axonal transport of opioid receptors in the sciatic nerve and increases their density in the inflamed tissue. Neuroscience (1993) 55:185–195.
  • LADURON P: Axonal transport of opiate receptors incapsaicin-sensitive nerves. Brain Res. (1984) 294:157–160.
  • SENGUPTA JN, GEBHART GF: Effect of K-opioidreceptors on mechanosensitive pelvic nerve afferent fibers innervating the colon of the rat. Gastroenterology (1995) 108:A686. Abstract.
  • SENGUPTA JN, SNIDER A, SU X, GEBHART GF: Effect of Kopioids in the inflamed rat colon. Pain (1999) 79:175–185.
  • DIOP L, RIVIERE P, PASCAUD X, JUNIEN JL: Peripheral1C-opioid receptors mediate the antinociceptive effect of fedotozine on the duodenal pain reflex in rat. Eur.J. Pharmacol. (1994) 271 :65–71.
  • DIOP L, RIVIERE P, PASCAUD X, DASSAUD M, JUNIEN JL: Role of vagal afferents in the antinociception produced by morphine and U50,488H in the colonic pain reflex in rats. Eur. Pharmacol. (1994) 271:181–187.
  • NESS TJ: K-Opioid receptors agonists differentially inhibit two classes of rat spinal neurons, excited by colorectal distension. Gastroenterology (1999) 117:388–394.
  • SENGUPTA JN, SU X, GEBHART G: K- but not µ- or8-opioids attenuate responses to distension of afferent fibers innervating the rat colon. Gastroenterology (1996) 111:968–980.
  • SCHOSSMANN JM, CHABAN VV, MCROBERTS JA et al.:Mechanical activation of dorsal root ganglion cells in vitro: comparison with capsaicin and modulation by K-opioids. Brain Res. (2000) 856:101–110.
  • MORTEAU 0, BUENO L: Animal models of intestinalinflammation. Gastroenterol. Clin. Biol. (1995) 19:204–214.
  • RIVIERE PJM, PASCAUD X, CHEVALIER E, JUNIEN JL:Fedotozine reversal of peritoneal irritation-induced ileus in rats: possible peripheral action on sensory afferents. j Pharmacol Exp. Ther. (1994) 270:846–850.
  • LANGLOIS A, DIOP L, FRIESE N et al.: Fedotozine blocks hypersensitive visceral pain in conscious rats: Action at peripheral K-opioid receptors. Eur. j Pharmacol. (1997) 324:211–217.
  • ALLESCHER HD, STORR M, PILLER C, BRANTL V, SCHUSDZIARRA V: Effect of opioid active therapeutics on the ascending reflex pathway in the rat ileum. Neuropeptides (2000) 34:181–186.
  • PASCAUD X, RIVIERE PJM, DIOP L, LANGLOIS A, JUNIEN JL: Fedotozine relieves visceral pain by acting through peripheral K-receptors. Increased potency during inflammation induced hyperalgesia in rats. In: Sensitive Gastrointestinal Disorders. Galmiche JP, Fraitag B (Eds.), John Libbey Eurotext, France (1995)43–53.
  • LANGLOIS A, DIOP L, RIVIERE PJ, PASCAUD X, JUNIEN JL: Effect of fedotozine on the cardiovascular pain reflex induced by distension of the irritated colon in the anaesthetized rat. Eur. j Pharmacol. (1994) 271:245–251.
  • GUE M, JUNIEN JL, BUNO L: The K-agonist fedotozine modulates colonic distension-induced inhibition of gastric motility and emptying in dogs. Gastroenterology (1994) 107:1327–1334.
  • GUE M, ALVINERIE M, JUNIEN JL, BURNO L: Stimulation of K opiate receptors in intestinal wall affects stress-induced increase of plasma cortisol in dogs. Brain Res. (1989) 502:143–148.
  • BUNO L, GUE M, FARGEAS M, ALVINERIE M, JUNIEN JL, FIORAMONTI J: Vagally mediated inhibition of acoustic stress involved cortisol release by orally administered K opioid substances in dogs. Endocrinology (1989) 124:1788–1793.
  • BARQUIST E, BONAZ B, MARTINEZ V, RIVIER J, ZINNER MJ, TACHE Y: Neuronal pathways involved in abdominal surgery-induced gastric ileus in rats. Am. J Physic)]. (1996) 270:R888–R894.
  • BONAZ B, RIVIERE PJ, SINNIGER V et al.: Fedotozine, a 1C-opioid agonist, prevents spinal and supra-spinal Fos expression induced by a noxious visceral stimulus in the rat. Neurogastroenterol. Mot. (2000) 12:135–147.
  • COFFIN B, BOOUHASSIRA D, CHOLLET R et al.: Effect ofthe K agonist fedotozine on perception of gastric distension in healthy humans. Aliment. Pharmacol. Ther. (1996) 10:919–925.
  • BOUHASSIRA D, SABATE JM, COFFIN B, LE BARS D, WILLER JC, JIAN R: Effects of rectal distensions on nociceptive flexion reflexes in humans. Am. J. Physiol. (1998) 275:G410–417.
  • RITCHIE J: Pain from distension of the pelvic colon by inflating a balloon in the irritable colon syndrome. Gut (1973) 14:125–132.
  • LEMBO T, MUNAKATA J, MERTZ H et al.: Evidence for the hypersensitivity of lumbar splanchnic afferents in irritable bowel syndrome. Gastroenterology (1994) 107:1686–1696.
  • READ NW: The effect of sleep deprivation on gastric emptying and food intake in healthy volunteers: Action of fedotozine. In: Sensitive Gastrointestinal Disorders. Galmiche JP, Fraitag B (Eds.), John Libbey Eurotext, France (1995):81–88.
  • BERGIN AJ, READ NW: The effects of sleep deprivation on rectal sensitivity in healthy volunteers. Eur. Gastroenterol. Hepatol (1993) 5:527–532.
  • ANONYMOUS: Human pharmacokinetic studies of fedotozine. Fedotozine Investigator Brochure. Jouveinal, Paris, France (1993):119–128.
  • FRAITAG B, HOMERIN M, HECKETSWEILER P: Double-blind dose-response multicenter comparison of fedotozine and placebo in treatment of non-ulcer dyspepsia. Dig. Dis. sa (1994) 39:1072–1077.
  • READ NW, ABITBOL JL, BARDHAN KD, WHORWELL PJ,FRAITAG B: Efficacy and safety of the peripheral K agonist fedotozine versus placebo in the treatment of functional dyspepsia. Gut (1997) 41:664–668.
  • DAPOIGNY M, ABITBOL JL, FRAITAG B: Efficacy ofperipheral K-agonist fedotozine versus placebo in treatment of Irritable Bowel Syndrome. A multicenter dose-response study. Dig. Dis. sa (1995) 40:2244–2248.
  • SOULARD CD, GUERIF S, PAYNE A, DAHL SG: Differen-tial effects of fedotozine compared to other K-agonists on diuresis in rats. J. Pharmacol Exp. Ther. (1996) 279:1379–1385.
  • BROQUA P, WETTSTEIN JG, ROCHER MN, RIVIERE PJ, DAHL SG: The discriminative stimulus properties of U50,488 and morphine are not shared by fedotozine. Eur. Neuropsychopharmacol (1998) 8:261–266.
  • RIVIERE PJ, PASCAUD X, JUNIEN JL: Fedotozine reversion of digestive motility disturbances in ileus. Action on sensory pathways through peripheral kappa receptors. In: Sensitive Gastrointestinal Disorders. Galmiche JP, Fraitag B (Eds.), John Libbey Eurotext, France (1995):33–41.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.